Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Stepan (SCL) Gains from Sales and Divestitures (2018 - 2025)

Stepan (SCL) has disclosed Gains from Sales and Divestitures for 8 consecutive years, with $27852.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Gains from Sales and Divestitures fell 39.72% year-over-year to $27852.0, compared with a TTM value of $27852.0 through Dec 2025, down 39.72%, and an annual FY2025 reading of $27852.0, down 39.72% over the prior year.
  • Gains from Sales and Divestitures was $27852.0 for Q4 2025 at Stepan, down from $46205.0 in the prior quarter.
  • Across five years, Gains from Sales and Divestitures topped out at $69314.0 in Q4 2022 and bottomed at $27852.0 in Q4 2025.
  • Average Gains from Sales and Divestitures over 4 years is $43319.2, with a median of $38055.5 recorded in 2023.
  • The sharpest move saw Gains from Sales and Divestitures crashed 56.85% in 2023, then soared 54.5% in 2024.
  • Year by year, Gains from Sales and Divestitures stood at $69314.0 in 2022, then plummeted by 56.85% to $29906.0 in 2023, then surged by 54.5% to $46205.0 in 2024, then tumbled by 39.72% to $27852.0 in 2025.
  • Business Quant data shows Gains from Sales and Divestitures for SCL at $27852.0 in Q4 2025, $46205.0 in Q4 2024, and $29906.0 in Q4 2023.